Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037402167> ?p ?o ?g. }
- W3037402167 endingPage "108064" @default.
- W3037402167 startingPage "108064" @default.
- W3037402167 abstract "Background Co-use of tobacco and cannabis has been associated with greater dependence on and lower quit rates for both substances. Tobacco/cannabis co-use among individuals with substance use disorders (SUDs), a population with high rates of cigarette smoking, may hinder the effectiveness of smoking cessation interventions. We examined rates of lifetime (i.e., ever vs. never) cannabis use among current cigarette smokers in SUD treatment, and we identified the subgroup who had used tobacco and cannabis together in the form of blunts and/or spliffs. We then examined variables associated with lifetime use of blunts and/or spliffs. Methods We surveyed 562 clients in 20 residential SUD treatment programs in California, USA, in 2019. Measures included demographics, lifetime use of any cannabis product, lifetime use of blunt/spliffs, patterns of tobacco use, and smoking cessation-related questions. We asked current cigarette smokers who also reported lifetime cannabis use whether they had ever used blunts and/or spliffs. We then assessed relationships of demographic, tobacco use, use of cannabis/tetrahydrocannabinol (THC) in e-cigarettes/vape pens, and smoking cessation–related variables with ever use versus never use of blunts/spliffs. Results Among 340 current cigarette smokers, 93.2% (n = 317) reported lifetime use of any cannabis product. Among current cigarette smokers with lifetime cannabis use, 64.4% reported lifetime blunt/spliff use. Compared to those who had never used blunts/spliffs, lifetime blunt/spliff users were more likely to be younger (OR = 0.93, 95% CI 0.90–0.95), more likely to report lifetime use of cigars/cigarillos (OR = 2.95, CI 1.37–6.32), and to have ever used cannabis/THC in e-cigarettes/vape pens (OR = 4.26, CI 1.54–11.80). They were less often ready to quit smoking within 30 days (OR = 0.37, CI 0.23–0.60), but more likely to want help with smoking cessation (OR = 2.39, CI 1.52–3.77). Conclusion Current cigarette smokers in SUD treatment reported a high prevalence of lifetime cannabis use. Smokers with a history of blunt/spliff use were more likely to report lifetime use of e-cigarettes/vape pens for cannabis/THC delivery. They wanted help to quit smoking, but felt less prepared to quit in the next 30 days. Cannabis co-use may warrant clinicians' attention when providing smoking cessation interventions during SUD treatment." @default.
- W3037402167 created "2020-07-02" @default.
- W3037402167 creator A5004677491 @default.
- W3037402167 creator A5007001955 @default.
- W3037402167 creator A5009752287 @default.
- W3037402167 creator A5022506875 @default.
- W3037402167 creator A5086233036 @default.
- W3037402167 date "2020-09-01" @default.
- W3037402167 modified "2023-10-03" @default.
- W3037402167 title "Correlates of lifetime blunt/spliff use among cigarette smokers in substance use disorders treatment" @default.
- W3037402167 cites W1530098667 @default.
- W3037402167 cites W1823504667 @default.
- W3037402167 cites W1988493110 @default.
- W3037402167 cites W2026901861 @default.
- W3037402167 cites W2035222743 @default.
- W3037402167 cites W2035501540 @default.
- W3037402167 cites W2092655105 @default.
- W3037402167 cites W2132026198 @default.
- W3037402167 cites W2165754195 @default.
- W3037402167 cites W2200597891 @default.
- W3037402167 cites W2214109033 @default.
- W3037402167 cites W2291921423 @default.
- W3037402167 cites W2308372010 @default.
- W3037402167 cites W2466016203 @default.
- W3037402167 cites W2518964438 @default.
- W3037402167 cites W2588481487 @default.
- W3037402167 cites W2609154517 @default.
- W3037402167 cites W2611527940 @default.
- W3037402167 cites W2624100118 @default.
- W3037402167 cites W275943166 @default.
- W3037402167 cites W2768198694 @default.
- W3037402167 cites W2776494598 @default.
- W3037402167 cites W2790432483 @default.
- W3037402167 cites W2799545489 @default.
- W3037402167 cites W2809155583 @default.
- W3037402167 cites W2888027611 @default.
- W3037402167 cites W2903580406 @default.
- W3037402167 cites W2904489157 @default.
- W3037402167 cites W2936586687 @default.
- W3037402167 cites W2990179100 @default.
- W3037402167 cites W2993946475 @default.
- W3037402167 cites W3000574423 @default.
- W3037402167 cites W3003940003 @default.
- W3037402167 cites W4295654925 @default.
- W3037402167 doi "https://doi.org/10.1016/j.jsat.2020.108064" @default.
- W3037402167 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7399210" @default.
- W3037402167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32741500" @default.
- W3037402167 hasPublicationYear "2020" @default.
- W3037402167 type Work @default.
- W3037402167 sameAs 3037402167 @default.
- W3037402167 citedByCount "4" @default.
- W3037402167 countsByYear W30374021672021 @default.
- W3037402167 countsByYear W30374021672022 @default.
- W3037402167 crossrefType "journal-article" @default.
- W3037402167 hasAuthorship W3037402167A5004677491 @default.
- W3037402167 hasAuthorship W3037402167A5007001955 @default.
- W3037402167 hasAuthorship W3037402167A5009752287 @default.
- W3037402167 hasAuthorship W3037402167A5022506875 @default.
- W3037402167 hasAuthorship W3037402167A5086233036 @default.
- W3037402167 hasBestOaLocation W30374021672 @default.
- W3037402167 hasConcept C105698618 @default.
- W3037402167 hasConcept C118552586 @default.
- W3037402167 hasConcept C141071460 @default.
- W3037402167 hasConcept C142724271 @default.
- W3037402167 hasConcept C144024400 @default.
- W3037402167 hasConcept C149923435 @default.
- W3037402167 hasConcept C2777056318 @default.
- W3037402167 hasConcept C2777843972 @default.
- W3037402167 hasConcept C2908647359 @default.
- W3037402167 hasConcept C3019190695 @default.
- W3037402167 hasConcept C71924100 @default.
- W3037402167 hasConcept C99454951 @default.
- W3037402167 hasConceptScore W3037402167C105698618 @default.
- W3037402167 hasConceptScore W3037402167C118552586 @default.
- W3037402167 hasConceptScore W3037402167C141071460 @default.
- W3037402167 hasConceptScore W3037402167C142724271 @default.
- W3037402167 hasConceptScore W3037402167C144024400 @default.
- W3037402167 hasConceptScore W3037402167C149923435 @default.
- W3037402167 hasConceptScore W3037402167C2777056318 @default.
- W3037402167 hasConceptScore W3037402167C2777843972 @default.
- W3037402167 hasConceptScore W3037402167C2908647359 @default.
- W3037402167 hasConceptScore W3037402167C3019190695 @default.
- W3037402167 hasConceptScore W3037402167C71924100 @default.
- W3037402167 hasConceptScore W3037402167C99454951 @default.
- W3037402167 hasFunder F4320308294 @default.
- W3037402167 hasLocation W30374021671 @default.
- W3037402167 hasLocation W30374021672 @default.
- W3037402167 hasLocation W30374021673 @default.
- W3037402167 hasOpenAccess W3037402167 @default.
- W3037402167 hasPrimaryLocation W30374021671 @default.
- W3037402167 hasRelatedWork W1995968479 @default.
- W3037402167 hasRelatedWork W2009515107 @default.
- W3037402167 hasRelatedWork W2023745385 @default.
- W3037402167 hasRelatedWork W2336304792 @default.
- W3037402167 hasRelatedWork W2345560366 @default.
- W3037402167 hasRelatedWork W2374854293 @default.
- W3037402167 hasRelatedWork W3008905761 @default.
- W3037402167 hasRelatedWork W3091293703 @default.